PAHC has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
PAHC has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
As of today (2024-04-30), Phibro Animal Health's current share price is $16.70. Phibro Animal Health's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2023 was $0.61. Phibro Animal Health's Cyclically Adjusted Price-to-FCF for today is 27.38.
The historical rank and industry rank for Phibro Animal Health's Cyclically Adjusted Price-to-FCF or its related term are showing as below:
During the past years, Phibro Animal Health's highest Cyclically Adjusted Price-to-FCF was 29.76. The lowest was 15.84. And the median was 24.48.
PAHC's Cyclically Adjusted Price-to-FCF is ranked better thanThe Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.
Phibro Animal Health's adjusted free cash flow per share data for the three months ended in Dec. 2023 was $0.509. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is $0.61 for the trailing ten years ended in Dec. 2023.
The historical data trend for Phibro Animal Health's Cyclically Adjusted Price-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Phibro Animal Health Quarterly Data | ||||||||||||||||||||
Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | |
Cyclically Adjusted Price-to-FCF | Get a 7-Day Free Trial | 24.17 | 28.08 | 24.43 | 21.06 | 19.07 |
For the Drug Manufacturers - Specialty & Generic subindustry, Phibro Animal Health's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Drug Manufacturers industry and Healthcare sector, Phibro Animal Health's Cyclically Adjusted Price-to-FCF distribution charts can be found below:
* The bar in red indicates where Phibro Animal Health's Cyclically Adjusted Price-to-FCF falls into.
Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.
Phibro Animal Health's Cyclically Adjusted Price-to-FCF for today is calculated as
Cyclically Adjusted Price-to-FCF | = | Share Price | / | Cyclically Adjusted FCF per Share |
= | 16.70 | / | 0.61 | |
= | 27.38 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Phibro Animal Health's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2023 is calculated as:
For example, Phibro Animal Health's adjusted Free Cash Flow per Share data for the three months ended in Dec. 2023 was:
Adj_FreeCashFlowPerShare | = | Free Cash Flow per Share | / | CPI of Dec. 2023 (Change) | * | Current CPI (Dec. 2023) |
= | 0.509 | / | 129.4194 | * | 129.4194 | |
= | 0.509 |
Current CPI (Dec. 2023) = 129.4194.
Phibro Animal Health Quarterly Data
Free Cash Flow per Share | CPI | Adj_FreeCashFlowPerShare | |
201403 | -0.139 | 99.695 | -0.180 |
201406 | -0.613 | 100.560 | -0.789 |
201409 | 0.338 | 100.428 | 0.436 |
201412 | 0.117 | 99.070 | 0.153 |
201503 | 0.393 | 99.621 | 0.511 |
201506 | 0.373 | 100.684 | 0.479 |
201509 | -0.262 | 100.392 | -0.338 |
201512 | -0.039 | 99.792 | -0.051 |
201603 | -0.149 | 100.470 | -0.192 |
201606 | 0.474 | 101.688 | 0.603 |
201609 | 0.390 | 101.861 | 0.496 |
201612 | 0.541 | 101.863 | 0.687 |
201703 | 0.805 | 102.862 | 1.013 |
201706 | 0.201 | 103.349 | 0.252 |
201709 | -0.005 | 104.136 | -0.006 |
201712 | 0.705 | 104.011 | 0.877 |
201803 | 0.461 | 105.290 | 0.567 |
201806 | 0.113 | 106.317 | 0.138 |
201809 | -0.118 | 106.507 | -0.143 |
201812 | 0.229 | 105.998 | 0.280 |
201903 | 0.197 | 107.251 | 0.238 |
201906 | 0.117 | 108.070 | 0.140 |
201909 | -0.278 | 108.329 | -0.332 |
201912 | 0.584 | 108.420 | 0.697 |
202003 | 0.471 | 108.902 | 0.560 |
202006 | -0.153 | 108.767 | -0.182 |
202009 | -0.141 | 109.815 | -0.166 |
202012 | 0.484 | 109.897 | 0.570 |
202103 | 0.226 | 111.754 | 0.262 |
202106 | -0.099 | 114.631 | -0.112 |
202109 | -0.090 | 115.734 | -0.101 |
202112 | 0.307 | 117.630 | 0.338 |
202203 | -0.096 | 121.301 | -0.102 |
202206 | -0.255 | 125.017 | -0.264 |
202209 | -0.836 | 125.227 | -0.864 |
202212 | -0.304 | 125.222 | -0.314 |
202303 | -0.041 | 127.348 | -0.042 |
202306 | 0.231 | 128.729 | 0.232 |
202309 | 0.215 | 129.860 | 0.214 |
202312 | 0.509 | 129.419 | 0.509 |
Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.
Thank you for viewing the detailed overview of Phibro Animal Health's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
Judith Weinstein | officer: See Remarks | C/O PHIBRO ANIMAL HEALTH CORP, 300 FRANK W. BURR BOULEVARD, STE 21, TEANECK NJ 07666 |
Alejandro Bernal | director | C/O ZOETIS INC., 10 SYLVAN WAY, PARSIPPANY NJ 07054 |
E Thomas Corcoran | director | |
Larry Lee Miller | officer: Chief Operating Officer | 8 HAZELWOOD COURT, WARREN NJ 07059 |
Damian Finio | officer: Chief Financial Officer | C/O IGI LABORATORIES, INC., 105 LINCOLN AVENUE, BUENA NJ 08310 |
Robin Aukerman | officer: President,North America Region | C/O PHIBRO, GLENPOINTE CENTRE EAST, 3RD FL, 300 FRANK W. BURR BLVD, STE 21, TEANECK NJ 07666 |
Daniel M Bendheim | director, officer: Exec. VP, Corporate Strategy | 300 FRANK W. BURR BOULEVARD, SUITE 21, TEANECK NJ 07666 |
Dean J Warras | officer: Pres Animal Health & Nutr N.A. | 5113 SPYGLASS HILL, QUINCY IL 62305 |
Jack Bendheim | director, 10 percent owner, officer: President and CEO | C/O EMPIRE RESOURCES, INC., 1 PARKER PLAZA, SUIET 10, FORT LEE NJ 07024 |
Bfi Co., Llc | 10 percent owner | 300 FRANK W. BURR BLVD., STE 21, TEANECK NJ 07666 |
Jonathan Bendheim | director | GLENPOINTE CENTRE EAST, 3RD FLOOR, 300 FRANK W. BURR BLVD. SUITE 21, TEANECK NJ 07666 |
Anthony Andolino | officer: SEE REMARKS | GLENPOINTE CENTRE EAST, 3RD FLOOR, 300 FRANK W. BURR BLVD., STE 21, TEANECK NJ 07666 |
Richard G Johnson | officer: Chief Financial Officer | 7 WEST 96TH STREET, APT. 11C, NEW YORK NY 10025 |
Gerald K Carlson | director | 2496 OLD BEACH ROAD, WAYZATA MN 55391 |
Thomas G Dagger | officer: SVP, Gen Counsel and Corp Sec | 41 WILCOX DRIVE, MOUNTAIN LAKES NJ 07046 |
From GuruFocus
By Business Wire Business Wire • 01-09-2023
By Business Wire Business Wire • 04-04-2022
By GuruFocus Research • 12-14-2023
By Business Wire Business Wire • 05-01-2023
By Business Wire • 01-16-2024
By Business Wire Business Wire • 07-25-2022
By Business Wire Business Wire • 02-06-2023
By Business Wire Business Wire • 02-14-2023
By GuruFocus Research • 01-11-2024
By Business Wire • 07-31-2023